Norden Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
2,575
+787
| +44% | +$350K | 0.12% | 161 |
|
|
2025
Q1 | $867K | Sell |
1,788
-60
| -3% | -$29.1K | 0.1% | 197 |
|
|
2024
Q4 | $744K | Buy |
1,848
+183
| +11% | +$73.7K | 0.08% | 251 |
|
|
2024
Q3 | $774K | Buy |
1,665
+286
| +21% | +$133K | 0.09% | 239 |
|
|
2024
Q2 | $646K | Buy |
1,379
+387
| +39% | +$181K | 0.13% | 171 |
|
|
2024
Q1 | $415K | Buy |
992
+377
| +61% | +$158K | 0.08% | 269 |
|
|
2023
Q4 | $250K | Buy |
+615
| New | +$250K | 0.04% | 232 |
|